OptimizeRx Corporation (OPRX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
OptimizeRx Corporation (OPRX) trades at $5.11 with AI Score 50/100 (Grade B). OptimizeRx Corporation provides digital health solutions, connecting life sciences companies with healthcare providers and patients. Market cap: $95.89M, Sector: Healthcare.
Last analyzed: May 10, 2026OPRX stock analysis for 2026: Analysts have set a consensus price target of $17.00 for OptimizeRx Corporation, suggesting 232.7% upside from the current price of $5.11. The AI MoonshotScore is 50/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
OPRX: 4/7 perspectives are bullish. Dominant signal: Seth Klarman bullish.
OptimizeRx Corporation (OPRX) Healthcare & Pipeline Overview
OptimizeRx Corporation operates as a digital health technology company, delivering solutions that streamline communication between pharmaceutical manufacturers, healthcare providers, and patients. Their focus on financial messaging, patient support, and brand awareness positions them within the evolving healthcare information services sector, leveraging technology to improve patient outcomes and medication adherence.
What Is the Investment Thesis for OPRX?
OptimizeRx Corporation operates in the growing digital health market, connecting pharmaceutical companies with healthcare providers and patients. With a market capitalization of $0.11 billion and a P/E ratio of 23.42, the company demonstrates profitability with a 4.7% profit margin and a strong 63.3% gross margin. Key value drivers include the increasing adoption of digital health solutions by pharmaceutical companies and healthcare providers, as well as the growing need for improved medication adherence and patient engagement. Growth catalysts include expanding the reach of their Mobile Health Messenger platform and leveraging their data analytics capabilities to provide more targeted and personalized patient support. Potential risks include increasing competition in the digital health space and regulatory changes affecting the pharmaceutical industry. The company's beta of 1.28 suggests higher volatility compared to the market.
Based on FMP financials and quantitative analysis
OPRX Key Highlights
- Market capitalization of $0.11 billion indicates the company's current valuation in the market.
- P/E ratio of 23.42 suggests investors are willing to pay $23.42 for every dollar of earnings.
- Profit margin of 4.7% demonstrates the company's ability to generate profit from its revenue.
- Gross margin of 63.3% indicates the company's efficiency in managing production costs.
- Beta of 1.28 suggests the stock is more volatile than the market.
Who Are OPRX's Competitors?
Who Are OPRX's Competitors?
OPRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HNGE Hinge Health, Inc. | $54.50 | +1.15% | 5B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.00 | +0.00% | $20.00M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| FOXO FOXO Technologies Inc. | $0.00 | +0.00% | 3K | 63 |
| AMWL American Well Corporation (AMWL) | $7.80 | -1.39% | 131M | 52 |
| DOCS Doximity, Inc. | $21.40 | +1.57% | $4.00B | 52 |
| DH Definitive Healthcare Corp. | $0.91 | +3.36% | 96M | 52 |
| GEHC GE HealthCare Technologies Inc. | $64.67 | -3.05% | $29.42B | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OPRX's Key Strengths?
- Established presence in the digital health technology space.
- Strong relationships with pharmaceutical manufacturers and healthcare providers.
- Proprietary technology platform for delivering digital health solutions.
- HIPAA-compliant data security and privacy practices.
What Are OPRX's Weaknesses?
- Relatively small market capitalization compared to larger competitors.
- Dependence on the pharmaceutical industry for revenue.
- Limited geographic reach outside of the United States.
- Potential for regulatory changes affecting the pharmaceutical industry.
What Could Drive OPRX Stock Higher?
- Expansion of the Mobile Health Messenger platform to new therapeutic areas.
- Potential partnerships with healthcare providers to integrate OptimizeRx's solutions into EHR systems.
- Increased adoption of digital health technologies by pharmaceutical companies and healthcare providers.
- Development and launch of new patient engagement solutions.
- Leveraging data analytics capabilities to provide more targeted and personalized patient support.
What Are the Key Risks for OPRX?
- Increasing competition in the digital health technology space.
- Potential for data breaches and security vulnerabilities.
- Changes in healthcare regulations and reimbursement policies.
- Dependence on the pharmaceutical industry for revenue.
- Economic downturn affecting the pharmaceutical industry.
What Are the Growth Opportunities for OPRX?
- Expansion into new therapeutic areas: OptimizeRx can expand its reach by targeting new therapeutic areas and developing specialized solutions for specific patient populations. The market for digital health solutions in chronic diseases, such as diabetes and cardiovascular disease, is particularly large and growing. By developing tailored programs and messaging for these areas, OptimizeRx can attract new pharmaceutical clients and increase its revenue. This expansion can be achieved within the next 1-2 years, leveraging the existing platform and infrastructure.
- Geographic expansion: OptimizeRx can expand its geographic reach by targeting new markets outside of the United States. The demand for digital health solutions is growing globally, particularly in countries with aging populations and increasing healthcare costs. By partnering with local healthcare providers and pharmaceutical companies, OptimizeRx can establish a presence in these markets and tap into new revenue streams. This expansion could begin within the next 2-3 years, starting with pilot programs in select countries.
- Enhanced data analytics capabilities: OptimizeRx can enhance its data analytics capabilities to provide more targeted and personalized patient support. By leveraging data on patient demographics, medication history, and adherence patterns, the company can develop customized messaging and interventions that are more likely to improve patient outcomes. This requires investment in data science and analytics infrastructure, but the potential return on investment is significant. The development and implementation of these enhanced capabilities can be achieved within the next 1-2 years.
- Partnerships with healthcare providers: OptimizeRx can strengthen its relationships with healthcare providers by offering them new tools and resources to improve patient care. This could include integrating its platform with electronic health record (EHR) systems, providing access to clinical decision support tools, and offering training and education programs for healthcare professionals. By becoming a trusted partner to healthcare providers, OptimizeRx can increase its market share and improve its brand reputation. These partnerships can be developed and expanded over the next 1-3 years.
- Development of new patient engagement solutions: OptimizeRx can develop new patient engagement solutions that go beyond medication adherence and address other aspects of patient health and well-being. This could include developing mobile apps for tracking symptoms, providing access to telehealth services, and offering personalized health coaching. By expanding its offerings to address a broader range of patient needs, OptimizeRx can attract new customers and increase its revenue. The development and launch of these new solutions can be phased in over the next 2-4 years.
What Opportunities Does OPRX Have?
- Expansion into new therapeutic areas and geographic markets.
- Development of new patient engagement solutions.
- Partnerships with healthcare providers and other healthcare organizations.
- Increased adoption of digital health technologies by pharmaceutical companies and healthcare providers.
What Threats Does OPRX Face?
- Increasing competition in the digital health technology space.
- Potential for data breaches and security vulnerabilities.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn affecting the pharmaceutical industry.
What Are OPRX's Competitive Advantages?
- Established relationships with pharmaceutical manufacturers and healthcare providers.
- Proprietary technology platform for delivering digital health solutions.
- HIPAA-compliant data security and privacy practices.
- Integration with electronic medical record (EMR) and e-prescribing (eRx) systems.
What Does OPRX Do?
Founded in 2006, OptimizeRx Corporation has evolved into a key player in the digital health technology space. The company provides a suite of solutions designed to connect life sciences organizations, healthcare providers, and patients, aiming to improve medication adherence, streamline communication, and enhance patient outcomes. OptimizeRx's initial focus was on leveraging electronic prescribing (eRx) systems to deliver financial messaging and patient support directly to physicians. This evolved into a broader platform offering brand awareness messaging, therapeutic support, and patient engagement tools. Their product suite includes a virtual patient support center, enabling access to sample vouchers, co-pay coupons, and other patient support resources through EMR and e-prescribe systems. They also offer brand support services, assisting pharmaceutical manufacturers in developing and implementing eRx media strategies. OptimizeRx operates a cloud-based Mobile Health Messenger platform, facilitating interactive health messaging for medication adherence and care coordination. Their HIPAA-compliant automated mobile messaging platform allows direct patient engagement, enhancing regimen compliance. The company also provides patient programs with treatment information, lifestyle trackers, and internet device connectivity. Headquartered in Rochester, Michigan, OptimizeRx continues to expand its offerings and market reach within the healthcare industry.
What Products and Services Does OPRX Offer?
- Connects life sciences organizations with healthcare providers and patients.
- Provides financial messaging services to deliver sample vouchers and co-pay coupons.
- Offers brand awareness and therapeutic support messaging services.
- Operates a cloud-based Mobile Health Messenger platform for medication adherence.
- Provides HIPAA-compliant automated mobile messaging for patient engagement.
- Offers patient programs with treatment and affordability information.
- Provides evidence-based physician engagement solutions using real-world data.
- Offers therapy initiation workflow focused on accelerating patient access to treatments.
How Does OPRX Make Money?
- Generates revenue by providing digital communication and engagement solutions to pharmaceutical manufacturers.
- Charges fees for delivering financial messaging and patient support services through EMR and e-prescribe systems.
- Earns revenue from brand awareness and therapeutic support messaging services.
- Offers subscription-based access to its Mobile Health Messenger platform.
What Industry Does OPRX Operate In?
OptimizeRx operates within the healthcare information services industry, which is experiencing significant growth due to the increasing adoption of digital health technologies and the growing need for improved patient engagement and medication adherence. The market is competitive, with companies offering various solutions for connecting pharmaceutical companies, healthcare providers, and patients. OptimizeRx differentiates itself through its focus on financial messaging, patient support, and brand awareness within the eRx ecosystem. The industry is expected to continue growing as healthcare providers and pharmaceutical companies seek to improve patient outcomes and reduce costs through digital solutions.
Who Are OPRX's Key Customers?
- Pharmaceutical manufacturers seeking to promote their products and improve patient adherence.
- Healthcare providers looking to access patient support resources and improve patient outcomes.
- Patients seeking information and support for their medications and health conditions.
OPRX Financials
OPRX Latest News
-
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
zacks.com · May 20, 2026
-
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
zacks.com · May 20, 2026
-
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates
Yahoo! Finance: OPRX News · May 15, 2026
-
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
zacks.com · May 15, 2026
OPRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OPRX.
Price Targets
Consensus target: $17.00
OPRX MoonshotScore
What does this score mean?
The MoonshotScore rates OPRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Who Are OPRX's Competitors?
Latest News
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
Leadership: Stephen L. Silvestro
CEO
Stephen L. Silvestro serves as the CEO of OptimizeRx Corporation. His background includes extensive experience in the healthcare technology sector, with a focus on driving innovation and growth. He has held leadership positions in various healthcare companies, where he was responsible for developing and implementing strategic initiatives to improve patient outcomes and streamline healthcare delivery. Silvestro's expertise spans areas such as digital health, data analytics, and healthcare IT. His career reflects a commitment to leveraging technology to address the challenges facing the healthcare industry.
Track Record: Under Stephen L. Silvestro's leadership, OptimizeRx has focused on expanding its digital health solutions and strengthening its relationships with pharmaceutical manufacturers and healthcare providers. Key achievements include the growth of the Mobile Health Messenger platform and the development of new patient engagement solutions. Silvestro has also overseen the company's efforts to enhance its data analytics capabilities and improve its HIPAA-compliant data security practices.
OptimizeRx Corporation Healthcare Stock: Key Questions Answered
What does OptimizeRx Corporation do?
OptimizeRx Corporation operates as a digital health technology company, providing solutions that connect pharmaceutical manufacturers, healthcare providers, and patients. Their platform facilitates the delivery of financial messaging, patient support, and brand awareness messaging through electronic medical record (EMR) and e-prescribing (eRx) systems. By streamlining communication and providing access to valuable resources, OptimizeRx aims to improve medication adherence, enhance patient outcomes, and drive efficiency within the healthcare ecosystem. The company's solutions also include a cloud-based Mobile Health Messenger platform and HIPAA-compliant automated mobile messaging for patient engagement.
What do analysts say about OPRX stock?
Analyst consensus on OptimizeRx Corporation (OPRX) reflects a mixed outlook, with some analysts highlighting the company's growth potential in the digital health market, while others express concerns about competition and regulatory risks. Key valuation metrics, such as the P/E ratio and market capitalization, are closely monitored to assess the company's financial performance and growth prospects. Growth considerations include the company's ability to expand its product offerings, penetrate new markets, and maintain its competitive edge in the evolving healthcare landscape. However, the information provided does not include any analyst ratings or price targets.
What are the main risks for OPRX?
OptimizeRx Corporation faces several risks, including increasing competition in the digital health technology space, which could put pressure on pricing and market share. Data breaches and security vulnerabilities pose a threat to the company's reputation and financial stability, given the sensitive nature of patient data. Changes in healthcare regulations and reimbursement policies could also impact the company's business model and revenue streams. Additionally, OptimizeRx's dependence on the pharmaceutical industry for revenue exposes it to the risk of economic downturns affecting the pharmaceutical sector. Managing these risks effectively is crucial for the company's long-term success.
What are the key factors to evaluate for OPRX?
OptimizeRx Corporation (OPRX) currently holds an AI score of 50/100, indicating moderate score. The stock trades at a P/E of 4.7x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $17.00 (+233% from $5.11). Key strength: Established presence in the digital health technology space. Primary risk to monitor: Increasing competition in the digital health technology space. This is not financial advice.
How frequently does OPRX data refresh on this page?
OPRX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OPRX's recent stock price performance?
Recent price movement in OptimizeRx Corporation (OPRX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $17.00 implies 233% upside from here. Notable catalyst: Established presence in the digital health technology space. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider OPRX overvalued or undervalued right now?
Determining whether OptimizeRx Corporation (OPRX) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 4.7. Analysts target $17.00 (+233% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying OPRX?
Before investing in OptimizeRx Corporation (OPRX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.
- Analyst opinions may vary.